260 related articles for article (PubMed ID: 3062958)
1. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
Bönner G
Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
[TBL] [Abstract][Full Text] [Related]
2. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
3. Kinin-related effects of angiotensin-converting enzyme inhibition.
Bönner G
Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
Kramer HJ; Glänzer K; Meyer-Lehnert H; Mohaupt M; Predel HG
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Waeber B; Nussberger J; Juillerat L; Brunner HR
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
[TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
Schrör K
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
[TBL] [Abstract][Full Text] [Related]
8. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
9. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
10. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
Andersen RS; Christensen S
Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
[TBL] [Abstract][Full Text] [Related]
11. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
Sambhi MP; Gavras H; Robertson JI; Smith WM
West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
[TBL] [Abstract][Full Text] [Related]
12. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
14. [Effect of enalapril maleate (MK-421) on blood pressure, renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension].
Shionoiri H; Akema N; Tanaka K; Miyazaki N; Gotoh E; Kaneko Y
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):759-65. PubMed ID: 6096606
[No Abstract] [Full Text] [Related]
15. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Brunner HR; Waeber B; Nussberger J
J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
Shimamoto K; Matsuki T; Iimura O
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
[TBL] [Abstract][Full Text] [Related]
17. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Neutel JM
J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of action of angiotensin I converting enzyme inhibitors].
Wiecek A
Przegl Lek; 1994; 51(4):193-7. PubMed ID: 8058992
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in patients with essential hypertension.
Kramer HJ; Predel HG; Meyer-Lehnert H
Clin Physiol Biochem; 1990; 8 Suppl 1():16-24. PubMed ID: 2257720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
